Sichenzia Ross Friedman Ference LLP Represents Tonix Pharmaceuticals in $43.5 Million Shelf Takedown

tonix pharmaceuticals

SRFF Named-Partner, Marc J. Ross, Leads Transaction Whose Proceeds Will fund Development of Medications for the Treatment of Fibromyalgia and Post-Traumatic Stress Disorder

NEW YORK CITY – February 12, 2014 Sichenzia Ross Friedman Ference LLP (SRFF), a leading corporate securities law firm headquartered in New York City, announces it represented Tonix Pharmaceuticals Holding Corp. (TNXP) in the closing of its confidentially marketed public offering, resulting in aggregate gross proceeds of approximately $43.5 million. The shelf takedown, which closed January 29, 2014, was led by SRFF named partner Marc J. Ross.

The SRFF team, which in addition to Ross as lead counsel included firm partner James M. Turner, advised Tonix in the underwritten public offering of 2,898,550 shares of the common stock at a price of $15.00 per share. Roth Capital Partners acted as the sole book-running manager for the offering and National Securities Corporation, a wholly owned subsidiary of National Holdings, Inc. (NHLD), acted as co-manager. Tonix granted the underwriters a 45-day option to acquire an additional 434,782 shares to cover overallotments in connection with the offering.

Tonix Pharmaceuticals develops prescription medications for disorders of the central nervous system, targeting conditions characterized by significant unmet medical needs, inadequate existing treatment options, and high dissatisfaction among both patients and physicians. Tonix expects to use the net proceeds of the offering to support the continued development of TNX-102 SL for the treatment of fibromyalgia, to initiate clinical trials of TNX-102 SL for the treatment of post-traumatic stress disorder, and to initiate clinical trials of TNX-201 for tension-type headache.

Avista Capital Partners

Last modified: 2013-12-16T13:14:39Z

Copyright 2013 . All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Media Contact:

pr@srf.law
(212) 930-9700

Sichenzia Ross Ference LLP

Sichenzia Ross Ference LLP is a full service law firm with a nationally recognized corporate, securities and litigation practice that provides experienced representation in all matters involving the securities industry.  In addition to handling routine to complex commercial matters, SRF’s renowned litigation department specializes in defending companies and individuals against all types of securities cases, including class action lawsuits, shareholder derivative actions, and matters involving allegations of fraud, misrepresentation or other securities violations.  The litigation team has also brought defamation lawsuits against companies and individuals related to market manipulation.  Additionally, it represents individuals and companies in investigations by the Securities and Exchange Commission (SEC) and other regulatory bodies.  The litigation team has a robust practice representing brokers and broker-dealers in arbitrations before the Financial Industry Regulatory Authority (FINRA).  These arbitrations typically involve claims of unsuitability, churning, unauthorized trading and other allegations of broker misconduct.  Finally, SRF has a burgeoning expungement practice, where it represents brokers seeking to have negative and harmful customer complaints removed from their industry records.  The firm complements its core practice areas with an established commercial real estate and trusts and estates practice.

Visit SRF's LinkedIn page
Sichenzia Ross Ference LLP
Click Here to Leave a Comment Below 0 comments

Leave a Reply: